Novo Nordisk stock rises after Wegovy recommended by UK’s drug price watchdog
Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4% after England’s drug price watchdog recommended the use of its best-selling drug Wegovy to prevent heart attacks and strokes, marking the first GLP-1 backed for this use in the country. Wegovy is mainly a weight loss treatment…
